October 18, 2019 - 12:30pm

Health and Human Services Commission
4900 North Lamar Blvd., Brown Heatly Building Public Hearing Room 1410/1420/1430
Austin, TX 78751

Add to My Calendar

Webcasting Available

This meeting will be webcast. To access the webcast, go to: https://hhs.texas.gov/about-hhs/communications-events/live-archived-meetings on the day and time of the meeting. Please e-mail Webcasting@hhsc.state.tx.us if you have any problems with the webcasting function.

  1. Call to Order and Welcome – Dr. Natalie Vanek, M.D., Acting Committee Chair
  2. Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC
  3. New Member Appointments – Dr. Natalie Vanek, M.D, Acting Committee Chair
  4. Member Recognition – Felipe Rocha, MSSW Director TB/HIV/STD Section and Dr. Natalie Vanek, M.D., Acting Committee Chair
  5. Adoption of Election Procedures and Election of Presiding Officers (Vote Required) – John Chacon, Advisory Committee Coordination Office, HHSC
  6. Review and Approval of July 19, 2019, Meeting Minutes (Vote Required) - Sallie Allen, Advisory Committee Coordination Office, HHSC
  7. Commissioners and Legislative Updates – Imelda Garcia, Associate Commissioner, DSHS
  8. Budget Update – Felipe Rocha, MSSW Director TB/HIV/STD Section
  9. Texas HIV Medication Program (THMP) Update – Rachel Sanor, THMP Manager
  10. Presentation on Livalo and Zypitamag prescribing information
    1. Kowa Pharmaceuticals: Livalo
    2. Medicure: Zypitamag
  11. Sub-Committee Reports
    1. Governance/Data – Nancy Miertschi
    2. Eligibility – Frank Rosas
    3. Formulary – Dr. Natalie Vanek, M.D.
  12. Medication Advisory Committee (MAC) to vote on addition of the following medications to THMP formulary (Vote Required)
    1. Livalo
    2. Zypitamag
  13. MAC to vote on addition of the top ten non-HIV medications to THMP formulary (Vote Required)
    1. Lisinopril
    2. Gabapentin
    3. Metoprolol tartrate
    4. Duloxetine
    5. Sertraline
    6. Amlodipine
    7. Atorvastatin
    8. Trazodone
    9. HCTZ
    10. Metformin
  14. Public Comment – Sallie Allen, Advisory Committee Coordination Office, HHSC
  15. Action items and agenda topics for next scheduled meeting January 17, 2020 – Dr. Natalie Vanek, M.D., Acting Committee Chair
  16. Adjourn – Dr. Natalie Vanek, M.D., Acting Committee Chair

Contact: Questions regarding agenda items, content, or meeting arrangements should be directed to Mary Richards, Pharmacy Coordinator, Department of State Health Services, 1‑800‑255-1090, or Mary.Richards@dshs.texas.gov.

This meeting is open to the public.  No reservations are required, and there is no cost to attend this meeting.

Persons with disabilities who plan to attend this meeting and require auxiliary aids or services are asked to contact Mary Richards, Department of State Health Services, telephone 1-800-255-1090 or mary.richards@dshs.texas.gov, at least 72 hours prior to the meeting so that appropriate arrangements may be made.